Yew Bio-Pharm Group, Inc. Deferred Revenue (Non-Current)
Yew Bio-Pharm Group, Inc. had Deferred Revenue (Non-Current) of $892.38 thousand as of 2019-12-31, per its 10-K filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2020-05-14
- 2019-12-31: Deferred Revenue, Noncurrent $892.38K.
- 2019-09-30: Deferred Revenue, Noncurrent $327.92K.
- 2019-06-30: Deferred Revenue, Noncurrent $340.83K.
- 2019-03-31: Deferred Revenue, Noncurrent $348.68K.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2019-12-31 | $892.38K 10-K · filed 2020-05-14 |
| 2019-09-30 | $327.92K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $340.83K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $348.68K 10-Q · filed 2019-05-22 |
| 2018-12-31 | $340.29K 10-K · filed 2020-05-14 |
| 2018-09-30 | $340.79K 10-Q · filed 2018-11-19 |
| 2018-06-30 | $353.52K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $372.60K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $359.65K 10-K · filed 2019-05-07 |
| 2017-09-30 | $351.64K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $345.29K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $121.91K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $120.97K 10-K · filed 2018-04-02 |